Category: Latest News

  • Provident Financial Misses Q4 Estimates as Profit Drops on Higher Costs, Weaker Fee Income

    Provident Financial Misses Q4 Estimates as Profit Drops on Higher Costs, Weaker Fee Income

    Provident Financial Holdings, Inc. (NASDAQ:PROV) reported fourth-quarter earnings that missed analyst projections, as a rise in operating costs and a drop in non-interest income led to a 17% decline in net profit compared to the same period a year earlier. For the quarter ending June 30, 2025, the parent of Provident Savings Bank posted net…

  • Revvity Surpasses Q2 Forecasts with Solid Revenue Growth Across Divisions

    Revvity Surpasses Q2 Forecasts with Solid Revenue Growth Across Divisions

    Revvity, Inc. (NYSE:RVTY) reported stronger-than-expected results for the second quarter, with steady revenue gains across its Life Sciences and Diagnostics segments, despite a complex economic backdrop. The company delivered adjusted earnings per share of $1.18, beating Wall Street expectations of $1.14. Total revenue reached $720 million, exceeding the average analyst forecast of $710.39 million. Compared…

  • Celcuity Shares Double After Landmark Breast Cancer Drug Trial Results

    Celcuity Shares Double After Landmark Breast Cancer Drug Trial Results

    Celcuity Inc. (NASDAQ:CELC) saw its stock soar by more than 100% on Monday following the release of groundbreaking Phase 3 trial data for its experimental breast cancer drug, gedatolisib. The therapy demonstrated unprecedented effectiveness in patients with hormone receptor-positive, HER2-negative advanced breast cancer. According to the company, the combination of gedatolisib with palbociclib and fulvestrant—known…

  • CervoMed Shares Surge After Promising Dementia Drug Trial Results

    CervoMed Shares Surge After Promising Dementia Drug Trial Results

    Shares of CervoMed Inc. (NASDAQ:CRVO) jumped 30% on Monday following the release of new clinical data suggesting that its investigational therapy, neflamapimod, may significantly slow disease progression in patients with dementia with Lewy bodies (DLB). The Boston-based biotech firm unveiled 32-week results from its RewinD-LB trial, indicating that patients who received neflamapimod experienced a 54%…

  • Gold Drops as BofA Cautions on Automated Selling Risk

    Gold Drops as BofA Cautions on Automated Selling Risk

    Gold prices slid on Monday amid warnings from Bank of America that further weakness could set off automatic selling by commodity trading advisors (CTAs). The metal has been facing persistent downside pressure, with prices approaching levels that could activate stop-loss mechanisms used by trend-based trading systems. Bank of America’s analysts believe that many trend-following investors…

  • Dollar strengthens, euro declines after U.S.-EU trade agreement

    Dollar strengthens, euro declines after U.S.-EU trade agreement

    The U.S. dollar gained ground on Monday as the euro slipped, following the announcement of a trade deal between the United States and the European Union just ahead of this week’s Federal Reserve meeting. By 04:25 ET (08:25 GMT), the Dollar Index, which tracks the greenback against six other major currencies, was up 0.4% at…

  • Oil Prices Gain on US-EU Trade Deal; OPEC+ Production Strategy Under Scrutiny

    Oil Prices Gain on US-EU Trade Deal; OPEC+ Production Strategy Under Scrutiny

    Oil prices in Asian trading saw a modest uptick on Monday after falling to three-week lows last week. The rebound was sparked by the announcement of a US-European Union trade agreement that eased fears of tariff hikes and boosted optimism about future energy demand. As of 21:47 ET (01:47 GMT), September Brent crude futures rose…

  • Dow Jones, S&P, Nasdaq,Wall Street Futures Climb Ahead of Key U.S.-EU Trade Pact and U.S.-China Negotiations

    Dow Jones, S&P, Nasdaq,Wall Street Futures Climb Ahead of Key U.S.-EU Trade Pact and U.S.-China Negotiations

    U.S. stock futures moved higher Monday following the announcement of a significant trade agreement between the United States and the European Union, easing fears of a trade war that could have disrupted global markets. Market focus now shifts to trade talks between the U.S. and China in Sweden, where reports indicate the two economic giants…

  • Tesla and Samsung Shares Climb After Musk Unveils Major $16.5 Billion Chip Deal

    Tesla and Samsung Shares Climb After Musk Unveils Major $16.5 Billion Chip Deal

    Shares of Tesla (NASDAQ:TSLA) and Samsung Electronics (USOTC:SSNHZ) rose on Monday following Elon Musk’s announcement of a multi-billion-dollar chip partnership between the two tech giants. The deal, valued at $16.5 billion, is expected to significantly support Samsung’s contract chip manufacturing business, which has struggled to turn a profit. Samsung’s stock jumped nearly 7% on the…

  • BCA’s Gertken: AI Advances May Trigger Political and Global Turbulence

    BCA’s Gertken: AI Advances May Trigger Political and Global Turbulence

    The rapid expansion of artificial intelligence may lead to both political unrest at home and rising global tensions, according to BCA Research’s Chief Geopolitical Strategist Matt Gertken. In a recent note, Gertken highlighted the potential for AI to disrupt traditional systems of governance and international cooperation. His comments followed two significant moves by the Trump…